Spondyloarthropathy and Sacroilitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Spondyloarthropathy and Sacroilitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

UnknownNot Applicable

NCT05655533

Added Value of Diffusion Weighted MRI in Evaluation of Sacroiliitis in Newly Diagnosed Patients of Spondyloarthropathy.

Spondyloarthropathy encompasses a group of chronic immune-mediated rheumatic inflammatory diseases characterized by axial joint inflammation, peripheral arthrit…

Location not specified50 participantsStarted 2022-12-10

Treatment: Magnetic resonance Imaging scanners of sacroiliac joints.

UnknownPhase 2

NCT04062695

Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

To evaluate the efficacy of Tofacitinib in reducing inflammation in the sacroiliac joints and spine on magnetic resonance imaging (MRI) in patients with active…

Germany80 participantsStarted 2020-08-04

Treatment: Tofacitinib 5 MG Oral Tablet [Xeljanz], Placebo oral tablet